Culprit and Nonculprit Recurrent Ischemic Events in Patients With Myocardial Infarction: Data From SWEDEHEART (Swedish Web System for Enhancement and Development of Evidence‐Based...

Por Varenhorst, Christoph, Hasvold, Pål, Johansson, Saga, Janzon, Magnus, Albertsson, Per, Leosdottir, Margret, Hambraeus, Kristina, James, Stefan, Jernberg, Tomas, Svennblad, Bodil, Lagerqvist, Bo
Publicado no J Am Heart Assoc (2018)

Genetic variation of CYP2C19 affects both pharmacokinetic and pharmacodynamic responses to clopidogrel but not prasugrel in aspirin-treated patients with coronary artery disease

Por Varenhorst, Christoph, James, Stefan, Erlinge, David, Brandt, John T., Braun, Oscar Ö., Man, Michael, Siegbahn, Agneta, Walker, Joseph, Wallentin, Lars, Winters, Kenneth J., Close, Sandra L.
Publicado em 2009

Lower mortality following pulmonary adverse events and sepsis with ticagrelor compared to clopidogrel in the PLATO study

Por Storey, Robert F., James, Stefan K., Siegbahn, Agneta, Varenhorst, Christoph, Held, Claes, Ycas, Joseph, Husted, Steen E., Cannon, Christopher P., Becker, Richard C., Steg, Ph Gabriel, Åsenblad, Nils, Wallentin, Lars
Publicado no Platelets (2014)

Ticagrelor vs. clopidogrel in patients with non-ST-elevation acute coronary syndrome with or without revascularization: results from the PLATO trial

Por Lindholm, Daniel, Varenhorst, Christoph, Cannon, Christopher P, Harrington, Robert A, Himmelmann, Anders, Maya, Juan, Husted, Steen, Steg, Philippe Gabriel, Cornel, Jan H, Storey, Robert F, Stevens, Susanna R, Wallentin, Lars, James, Stefan K
Publicado em 2014